Patents : |  |
| US Patent No. | Title |
| 7538091 | Intracellular delivery of biological effectors
|
| 7563760 | P-selectin ligand protein
|
| 7566565 | PC5 as a factor IX propeptide processing enzyme
|
| 7569391 | Method for making .beta.-secretase co-crystals complexed with a ligand
|
| 7569544 | Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents
|
| 7569547 | Inhibiting furin with polybasic peptides
|
| 7571055 | Systemic lupus erythematosus
|
| 7572591 | Construct comprising recognition domain of antibody against von Willebrand factor-specific cleaving enzyme
|
| 7572596 | Modulation of the neuroendoctrine system as a therapy for motor neuron disease
|
| 7572618 | Polynucleotides encoding novel PCSK9 variants
|
| 7572904 | Nucleic acids encoding respiratory syncytial virus subgroup B strain 9320
|
| 7560431 | Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents
|
| 7560287 | Long wavelength engineered fluorescent proteins
|
| 7541431 | Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto
|
| 7541434 | Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
|
| 7544484 | Nucleic acids encoding membrane-binding proteins and methods of using same
|
| 7544776 | Long wavelength engineered fluorescent proteins
|
| 7544788 | Isolated nucleic acid molecule encoding a neurotrophic growth factor
|
| 7547437 | Method of treating fibrosis
|
| 7553930 | BAFF variants and methods thereof
|
| 7556941 | Materials and methods for preparing dimeric growth factors
|
| 7556957 | Coronavirus-like particles comprising functionally deleted genomes
|
| 7557188 | Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide
|
| 7575872 | Antibody against von Willebrand factor cleaving enzyme and assay system using the same
|
| 7575876 | Biomarkers for neurodegenerative disorders
|
| 7575897 | Highly phosphorylated and sulfated recombinant factor IX
|
| 7601351 | Antibodies against protective antigen
|
| 7601518 | Secretion of neublastin
|
| 7601540 | Gamma secretase notch biomarkers
|
| 7601886 | Production of transgenic plants with increased seed yield
|
| 7604823 | Synergistic HIV/AIDS and/or immune disease phyto-nutraceutical composition
|
| 7605251 | Compositions and methods for inhibiting expression of the PCSK9 gene
|
| 7608451 | Gene regulation in transgenic animals using a transposon-based vector
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7612035 | Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
|
| 7612163 | Prokineticin 2.beta. peptide and its use
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7597883 | Methods for promoting growth of bone, ligament, and cartilage
|
| 7579169 | Hereditary hemochromatosis gene
|
| 7579468 | Methods of modulating neurotrophin-mediated activity
|
| 7585461 | Tissue pathogen inactivation/removal process
|
| 7585507 | Nucleic acid molecules and polypeptides for immune modulation
|
| 7585667 | Negative strand RNA virus replicon
|
| 7589178 | Thrombin-cleavable chimeric proteins
|
| 7592010 | Albumin fusion proteins
|
| 7592014 | Stabilized viral envelope proteins and uses thereof
|
| 7595385 | Polymorphisms in the region of the human hemochromatosis gene
|
| 7596836 | Nose and throat anti-influenza solution and method of use
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
